Kyle Gano, Chief Business Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,246 shares at $103.33 ($335K) on 2020-02-07, disclosed to the SEC on 2020-02-11.
Seasonal sale ($335k) by Chief Business Development Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.33 | 1,623 | $168K | 50.0% |
| 2 | $103.33 | 1,623 | $168K | 50.0% |
| Total | $103.33 avg | 3,246 | $335K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |